#-supreme-cellcarta-differentiators-7-714{items-data:[{"text":"Platform Agnostic Approach"},{"text":"Expert In-House Pathologists"},{"text":"Global Execution"},{"text":"AI-Assisted Image Analysis"},{"text":"Cross-Site Harmonization"}]}#-supreme-cellcarta-faq-11-714{items-data:[{"faq_question":"What staining platforms does CellCarta use?","faq_answer":"<p>CellCarta runs <a href=\"/capabilities/histopathology/ihc/\" target=\"_self\">IHC</a> assays across a multi-instrument staining environment:Dako Autostainer Link 48 and Omnis;Ventana BenchMark Ultra,Ultra Plus,Discovery Ultra,and Special Stains System;Lunaphore COMET;Abbott VIP 2000 and Thermobrite;Sakura Tissue-Tek Prisma;and Leica Biosystems Bond Rx and Bond III.</p>\n<p>Chromogenic and fluorescent labeling methods are available across all platforms,giving study teams flexibility to select the instrument format most appropriate for their assay type and tissue. The same instruments and protocols are cross-validated across CellCarta's laboratories in the USA,Belgium,and China,ensuring staining results are directly comparable regardless of which site processes the samples.</p>"},{"faq_question":"Which whole slide scanners does CellCarta offer?","faq_answer":"<p>CellCarta's imaging infrastructure spans multiple vendors:3DHistech (Pannoramic 250 and Pannoramic 1000),Ventana (DP 200 and DP 600),Leica Biosystems (GT450 Dx,AT2,and AT Turbo),Lunaphore COMET,RareCyte CyteFinder HT,Zeiss Axio Scan.Z1,Akoya PhenoImager,and BioView (Duet-3 and Allegro Plus). Both brightfield and fluorescent modalities are covered,supporting all standard staining types including IHC,mIF,and ISH. Whole slide scanning is available as a stand-alone digitization service or integrated within a full digital pathology program.</p>"},{"faq_question":"What image analysis software does CellCarta use?","faq_answer":"<p>Image analysis is performed using a portfolio of commercially validated AI-assisted software tools:Indica Labs HALO&reg;,Visiopharm&reg;,Lunaphore HORIZON,Akoya inForm&reg;,CyteHub&reg;,SoloWeb,navify&reg;by Roche,and the Lunit SCOPE&reg;suite. These platforms support cell phenotyping,nuclear segmentation,tissue classification,density quantification,and spatial biomarker data extraction. Custom algorithms can be developed for specific clinical programs when commercially available tools do not meet study requirements. All image analysis workflows are 21 CFR Part 11-compliant,supporting data integrity requirements for regulated clinical submissions. An <a href=\"/capabilities/histopathology/pathology-team/\" target=\"_self\">in-house team of 20+ pathologists</a> performs rigorous QC review across all datasets before results are delivered.</p>"}]}#-supreme-cellcarta-service-blocks-8-714{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-73-Copy-scaled.jpg","image_alt":"Scientist performing immunofluorescence and IHC tissue staining for antigen abundance and localization analysis","title":"IHC Services","description":"Insights into the abundance,distribution,and localization of your antigens of interest.","button_text":"Discover","button_url":"/capabilities/histopathology/if-ihc/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Hybridization-Services-Hero-108.jpg","image_alt":"In situ hybridization assay for precise localization and quantification of DNA,mRNA,and microRNA in clinical tissue samples","title":"In Situ Hybridization (ISH)","description":"Precise localization and quantification of nucleic acids including DNA,mRNA,and microRNA.","button_text":"Discover","button_url":"/capabilities/histopathology/ish/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/08/CellCarta-616-scaled.jpg","image_alt":"Digital pathology scientist using AI-powered whole slide image analysis platform for clinical trial biomarker evaluation","title":"Digital Pathology","description":"Cutting-edge digital and AI-powered analysis to advance your clinical trials.","button_text":"Discover","button_url":"/capabilities/histopathology/digital-pathology/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-4-714{oxy-supreme-cellcarta-tab-content-content-heading-tag:h3;oxy-supreme-cellcarta-tab-content-content-heading-size:default;oxy-supreme-cellcarta-tab-content-content-body-size:default;tabs-data:[{"tab_title":"Staining Technology","content_title":"","content_body":"<p>We take an agnostic approach to assay development and clinical testing,delivering services across a large suite of staining instruments.</p>\n<ul>\n<li>Leica Bond and Bond III</li>\n<li>Lunaphore COMET</li>\n<li>Abbott VIP 2000 and Thermobrite</li>\n<li>Ventana BenchMark Ultra Plus,Special Stains System,and Discovery Ultra</li>\n<li>Dako Link 48 Autostainer and Omnis</li>\n<li>Sakura Tissue-Tek Prisma</li>\n</ul>\n<p>Unsure which platform is best suited for your study? Our histopathology team can help inform your selection.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Staining-Technology-tab-641.jpg","image_alt":"Scientist operating an automated immunohistochemistry staining instrument in a CellCarta histopathology laboratory"},{"tab_title":"Imaging Platforms","content_title":"","content_body":"<p>We offer a multitude of brightfield and fluorescent scanners for cell imaging,including:</p>\n<ul>\n<li>3Dhistech P250 and P1000</li>\n<li>Akoya Phenolmager</li>\n<li>BioView Duet-3 and Allegro Plus</li>\n<li>Leica GT450 Dx,AT2,and AT Turbo</li>\n<li>Lunaphore COMET</li>\n<li>RareCyte CyteFinder HT</li>\n<li>Ventana DP 200 and DP 600</li>\n<li>Zeiss Axio Scan Z1</li>\n</ul>\n<p>Our imaging platforms have been implemented in over 1000 clinical trials,and can support your study at the exploratory,primary,and secondary endpoint.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Imaging-Platforms-tab-588.jpg","image_alt":"Scientists reviewing digital whole slide images on large monitors in a CellCarta digital pathology imaging laboratory"},{"tab_title":"H&E Staining","content_title":"","content_body":"<p>We can perform hematoxylin and eosin (H&E) staining on your clinical samples,allowing you to investigate therapeutic efficacy,including tissue inflammation,tumor-infiltrating lymphocytes (TILs),and tertiary lymphoid structures (TLS).</p>\n<p>Our H&E staining services can visualize cellular and tissue structures in FFPE,fresh,and frozen tissue.</p>\n<p>All H&E scoring and annotation is performed by our <a href=\"/capabilities/histopathology/pathology-team/\" target=\"_self\">in-house pathologists</a>.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/HE-Staining-tab-90.jpg","image_alt":"Pathologist examining hematoxylin and eosin stained tissue slide for tumor-infiltrating lymphocyte assessment"},{"tab_title":"Image Analysis","content_title":"","content_body":"<p>Our pathologists and imaging scientists have expertise implementing AI-supported digital image analysis platforms for dataset evaluation,including:</p>\n<ul>\n<li>CyteHub&reg;</li>\n<li>Halo AI</li>\n<li>HORIZON</li>\n<li>Visiopharm</li>\n<li>inForm&reg;</li>\n<li>Solo Web</li>\n<li>NavifyDP</li>\n</ul>\n<p>Our pathologists perform rigorous review and QC of all datasets,ensuring your study&rsquo;s results are high-quality and reproducible.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Image-Analysis-tab-731.jpg","image_alt":"Pathologist and imaging scientist reviewing AI-assisted digital image analysis results on dual-monitor workstation"}]}